Power Law company profile

Prometheus Biosciences

Biotech & Life Sciences · San Diego, United States · Founded 1995 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$8.87B

Market cap · 2026

Revenue

$6.8M

Latest reported FY

Investors

10 investors on Prometheus Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 10 investors entered at this stage

Ascend Global Investments

RTW Investments

Eventide Asset Management

Cedars-Sinai

Point72

Patent intelligence

$37M patent portfolio · 47 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$37M

0.41% of market cap · 55.1× smaller than top peer Ablynx ($2B)

47 active patent families

Where Prometheus Biosciences innovates Molecular biologyAutoimmune inflammatory bowel diseaseBowels diseasesAntiendomysial antibodiesUlcerative colitis

Above peer median on Strategic · Below peer median on Market

Quality vs same-sector peers

Prometheus Biosciences on the five Patsnap quality dimensions

Prometheus Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Prometheus Biosciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Prometheus Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Prometheus Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo